|
|
J
Jong-Hyeon Jeong, PhD
Associate Professor,
Biostatistics
Statistician, NSABP
Education
BA, Kang-Weon National
University
MA, University of Rochester
PhD, University of Rochester
Research Interests
Currently collaborates
on clinical trials in the National Surgical Adjuvant Breast and
Bowel Project (NSABP). Methodological interests are presently related
to survival analysis; specifically interested in (1) inference on residual lifetimes, (2) inference on cumulative incidence function, and (3) frailty models.
(Health
Sciences Faculty Research Interests Project)
Courses
BIOST 2043: Introduction to Statistical Theory I
BIOST 2044: Introduction to Statistical Theory II
BIOST 2049: Applied Regression Analysis
BIOST 2051: Statistical Estimation Theory
BIOST 2054/STAT 2261: Survival Analysis
Selected Publications
Methodology Papers:
Oakes, D. and Jeong, J. (1998). Frailty models and rank tests. Lifetime Data Analysis 4, 209‑228.
Jeong, J. and Oakes, D. (2003). On the asymptotic relative efficiency of estimates from Cox’s model. Sankhya 65, 411-421.
Jeong, J. and Jung, S. (2006). Rank tests for clustered survival data when dependent subunits are randomized. Statistics in Medicine 25, 361-373.
Jeong, J. and Fine, J. (2006). Direct parametric inference for cumulative incidence function. Journal of Royal Statistical Society-Series C (Applied Statistics) 55, 187-200.
Jeong, J. (2006). A new parametric distribution for modeling cumulative incidence function: Application to breast cancer data. Journal of Royal Statistical Society -Series A (Statistics in Society) 169, 289-303.
Jeong, J. and Fine, J. (2007). Parametric regression on cumulative incidence function. Biostatistics 8, 184-196.
Jeong, J., Jung, S, and Joseph Costantino. (2008). Nonparametric inference on median residual lifetimes in breast cancer patients. Biometrics 64, 157-163.
Collaborative
Papers:
Fisher, B, Jeong, J., Anderson, S. Bryant, J., Fisher, E., and Wolmark Norman. (2002). Twenty-five year findings from a randomized clinical trial comparing radical mastectomy with total mastectomy and with total mastectomy followed by radiation therapy. The New England Journal of Medicine, 347, 567-575.
Fisher, B., Jeong, J., Bryant, J., Mamounas, E.P., Dignam, J., and Wolmark, N. (2004). Treatment of lymph node-negative, estrogen receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. The Lancet 364, 858-868.
Fisher, B, Jeong, J. Anderson, S., et al. (2004). Treatment of lymph node-negative, estrogen receptor-negative breast cancer: Long-term findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. Journal of the National Cancer Institute 96, 1823-1831.
Taghian, A., Jeong, J., Mamounas, E., Parda, D.M., Deutsch, M., Costantino, J.P., and Wolmark, N. (2006). Low loco-regional recurrence rate among node negative breast cancer patients with tumor size 5cm and larger treated by mastectomy with or without adjuvant systemic therapy and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Journal of Clinical Oncology 24, 3937-3932.
Mamounas, M., Jeong, J.,Wickerham, L. et al. (2008). Benefit from exemestane as extended Adjuvant therapy after five years of tamoxifen: results from the NSABP B-33 trial. Journal of Clinical Oncology 26, 1965-1971.
Mamounas, EP, Lembersky, B., Jeong, J. et al. NSABP B-42: A clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging disease-free survival in postmenopausal women with hormone receptor-positive breast cancer. Clinical Breast cancer, In press.
Contact Information
318B Parran Hall
130 DeSoto Street
Pittsburgh, PA 15261
Telephone: 412-624-8549
Facsimile: 412-624-2183
Email: jeong@nsabp.pitt.edu
|
 |
